• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

nanoMR

edit

nanoMR has developed the first system for rapid isolation of rare cells from complex matrices at levels of 1 cell/mL or lower. The immunomagnetic capture system can target multiple cell types simultaneously, for example capturing bacteria and fungi from bloodstream infections, or specific cell types, such as circulating tumor, or fetal, cells, in less than 30 minutes.

Recent Milestones

edit

• 
  nanoMR received $13M in Series B funding. (7/19/11)
  Posted 7/19/11 at 5:47am via yahoo.com
• 
  nanoMR added Sergey A. Dryga as VP of Immunochemistry.
  Posted 1/1/13 at 6:16am
• 
  nanoMR added Victor Esch as President & CEO.
  Posted 1/1/13 at 6:16am
• 
  nanoMR added Colin W. Dykes as Chief Scientific Officer.
  Posted 1/1/13 at 6:16am

Videos

Screenshots

edit

Above: nanoMR
Uploaded: 7/19/11

Sources

1. nanoMR Announces $13 Million Series B Financing (ca.finance.yahoo.com) [edit]